Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.88 -0.02 (-1.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) EBT Margin (2010 - 2026)

Updated

Lexicon Pharmaceuticals' EBT Margin was -3835.26% in Q2 2026, down 3848.20 percentage points from 12.94% a year earlier and down 3830.54 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) EBT Margin (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lexicon Pharmaceuticals' EBT Margin was -131.43% through Jun 30, 2026, up 71.15 percentage points year-over-year; for FY2025, it was -98.21%, up 536.00 percentage points from FY2024.

  • EBT Margin has now increased for three consecutive years, with a five-year change of +145.90 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -634.20% in FY2024 (+13630.75 pp), -14264.95% in FY2023 (+60224.26 pp), -74489.21% in FY2022 (-45040.22 pp) and -29448.99% in FY2021 (-29204.88 pp).
  • The Q2 2026 figure marks the lowest quarterly EBT Margin since Q1 2024.
  • Compared with a year earlier, EBT Margin was higher in six of the last eight quarters, with an average year-over-year change of +5359.82 percentage points.
  • The best year-over-year quarter for EBT Margin over five years was Q1 2024 (a gain of 133334.06 percentage points); the worst was Q4 2021 (a drop of 180274.41 percentage points).
  • Per Business Quant data, LXRX's EBT Margin in the three quarters before Q2 2026 was -4.72% (Q1 2026), -269.07% (Q4 2025) and -85.93% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Lexicon Pharmaceuticals 849.05 Mn 275.61 Mn 653,000.00 -3,835.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,835.26%
Mar 31, 2026 -4.72%
Dec 31, 2025 -269.07%
Sep 30, 2025 -85.93%
Jun 30, 2025 12.94%
Mar 31, 2025 -2,034.79%
Dec 31, 2024 -123.28%
Sep 30, 2024 -3,639.60%
Jun 30, 2024 -3,360.90%
Mar 31, 2024 -4,011.77%
Dec 31, 2023 -6,657.69%
Sep 30, 2023 -33,043.21%
Jun 30, 2023 -14,574.13%
Mar 31, 2023 -137,345.83%
Dec 31, 2022 -112,075.00%
Sep 30, 2022 -61,433.33%
Jun 30, 2022 -70,600.00%
Dec 31, 2021 -183,035.71%
Sep 30, 2021 -100,578.26%
Jun 30, 2021 -7,747.01%
API Access

Lexicon Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=LXRX&period=max&api_key=YOUR_API_KEY